Abstract: This study investigated indoor radon concentrations in modern residential buildings in the Cold Area and Severe Cold Area in China. A total of 19 cities covering 16 provinces were selected with 1,610 dwellings measured for indoor radon concentration. The arithmetic mean and geometric mean of indoor radon concentration were 68 Bq m -3 and 57 Bq m -3 , respectively. It was found that indoor radon concentrations were much higher in the Severe Cold Area than those in the Cold Area. The indoor radon concentrations showed an increasing trend for newly constructed buildings. It was estimated that the average effective dose from inhalation of indoor radon is 2.15 mSv and 1.60 mSv for the Severe Cold Area and Cold Area, respectively. The more and more rigid energy-saving design for residential buildings in the Severe Cold Area and Cold Area has an obvious impact on the increased trend of indoor radon due to extremely low air exchange rate in China.
{"title":"Indoor Radon Concentrations in Severe Cold Area and Cold Area and Impact of Energy-saving Design on Indoor Radon in China.","authors":"Yunyun Wu, Yanchao Song, Changsong Hou, Hongxing Cui, Bing Shang, Haoran Sun","doi":"10.1097/HP.0000000000001869","DOIUrl":"10.1097/HP.0000000000001869","url":null,"abstract":"<p><strong>Abstract: </strong>This study investigated indoor radon concentrations in modern residential buildings in the Cold Area and Severe Cold Area in China. A total of 19 cities covering 16 provinces were selected with 1,610 dwellings measured for indoor radon concentration. The arithmetic mean and geometric mean of indoor radon concentration were 68 Bq m -3 and 57 Bq m -3 , respectively. It was found that indoor radon concentrations were much higher in the Severe Cold Area than those in the Cold Area. The indoor radon concentrations showed an increasing trend for newly constructed buildings. It was estimated that the average effective dose from inhalation of indoor radon is 2.15 mSv and 1.60 mSv for the Severe Cold Area and Cold Area, respectively. The more and more rigid energy-saving design for residential buildings in the Severe Cold Area and Cold Area has an obvious impact on the increased trend of indoor radon due to extremely low air exchange rate in China.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"682-687"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-08-01DOI: 10.1097/HP.0000000000001873
Sylvia S Rhodes, Janelle E Jesikiewicz, Nikhil Yegya-Raman, Kavya Prasad, Alexandra Dreyfuss, David A Mankoff, Neil K Taunk
Abstract: Institutional radiation safety committees review research studies with radiation exposure. However, ensuring that the potential patient benefit and knowledge gained merit the radiation risks involved often necessitates revisions that inadvertently delay protocol activations. This quality-improvement study analyzed protocols, identified factors associated with approval time by a radiation safety committee, and developed guidelines to expedite reviews without compromising quality. Clinical protocols submitted to the University of Pennsylvania's Radiation Research Safety Committee (RRSC) for review between 2017 and 2021 were studied. Protocol characteristics, review outcome, stipulations, and approval times were summarized. Statistical analysis (Spearman's rho) was used to investigate stipulations and approval time; rank-sum analysis (Kruskal-Wallis or Wilcoxon) was used to determine whether approval time differed by protocol characteristics. One hundred ten (110) protocols were analyzed. Approximately two-thirds of protocols used approved radiopharmaceuticals to aid investigational therapy trials. Twenty-three percent (23%) of protocols received RRSC approval, and 73% had approval withheld with stipulations, which included requests for edits or additional information. Submissions had a median of three stipulations. Median and mean RRSC approval times were 62 and 80.1 d, and 41% of protocols received RRSC approval after IRB approval. RRSC approval time was positively correlated with stipulations (Spearman's rho = 0. 632, p < 0.001). RRSC approval time was longer for studies using investigational new drugs (median 80 d) than approved radiopharmaceuticals (median 57 d, p = 0.05). The review process is lengthy and may benefit from changes, including publishing standardized radiation safety language and commonly required documents and encouraging timely response to stipulations.
{"title":"Optimizing Regulatory Reviews for Clinical Protocols That Use Radiopharmaceuticals: Findings of the University of Pennsylvania Radiation Research Safety Committee.","authors":"Sylvia S Rhodes, Janelle E Jesikiewicz, Nikhil Yegya-Raman, Kavya Prasad, Alexandra Dreyfuss, David A Mankoff, Neil K Taunk","doi":"10.1097/HP.0000000000001873","DOIUrl":"10.1097/HP.0000000000001873","url":null,"abstract":"<p><strong>Abstract: </strong>Institutional radiation safety committees review research studies with radiation exposure. However, ensuring that the potential patient benefit and knowledge gained merit the radiation risks involved often necessitates revisions that inadvertently delay protocol activations. This quality-improvement study analyzed protocols, identified factors associated with approval time by a radiation safety committee, and developed guidelines to expedite reviews without compromising quality. Clinical protocols submitted to the University of Pennsylvania's Radiation Research Safety Committee (RRSC) for review between 2017 and 2021 were studied. Protocol characteristics, review outcome, stipulations, and approval times were summarized. Statistical analysis (Spearman's rho) was used to investigate stipulations and approval time; rank-sum analysis (Kruskal-Wallis or Wilcoxon) was used to determine whether approval time differed by protocol characteristics. One hundred ten (110) protocols were analyzed. Approximately two-thirds of protocols used approved radiopharmaceuticals to aid investigational therapy trials. Twenty-three percent (23%) of protocols received RRSC approval, and 73% had approval withheld with stipulations, which included requests for edits or additional information. Submissions had a median of three stipulations. Median and mean RRSC approval times were 62 and 80.1 d, and 41% of protocols received RRSC approval after IRB approval. RRSC approval time was positively correlated with stipulations (Spearman's rho = 0. 632, p < 0.001). RRSC approval time was longer for studies using investigational new drugs (median 80 d) than approved radiopharmaceuticals (median 57 d, p = 0.05). The review process is lengthy and may benefit from changes, including publishing standardized radiation safety language and commonly required documents and encouraging timely response to stipulations.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"702-711"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract: Uranium is naturally occurring in groundwater used for drinking; however, health risks from naturally occurring concentrations are uncertain. Uranium can cause both radiological and chemical toxicity following ingestion. Bladder and kidneys receive a dose when uranium is excreted into the urine. Investigate the association between uranium in drinking water and bladder cancer risk in a case-control study. A population-based bladder cancer case-control study was conducted in 11 counties of southeastern Michigan. A total of 411 cases and 566 controls provided drinking water and toenail samples and answered questions about lifestyle and residential history. Uranium was measured in drinking water and toenails, and its association with bladder cancer was assessed via unconditional logistic regression models. Median uranium concentration in water was 0.12 μg L -1 , with a maximum of 4.99 μg L -1 , and median uranium concentration in toenails was 0.0031 μg g -1 . In adjusted regression models, there was a suggestion of a protective effect among those exposed to the upper quartile of uranium in drinking water (HR = 0.64, 95% CI: 0.43, 0.96) and toenails (HR 0.66; 95% CI 0.45, 0.96) compared to those in the lowest quartile. Our objective is to investigate additional adjustment of drinking water source at home residence at time of recruitment to address potential selection bias and confounding attenuated results toward the null for drinking water uranium (HR = 0.68, 95% CI: 0.44, 1.05) and toenail uranium (HR = 0.80, 95% CI: 0.53, 1.20). This case-control study showed no increased risk of bladder cancer associated with uranium found in drinking water or toenails.
{"title":"Uranium in Drinking Water and Bladder Cancer: A Case-control Study in Michigan.","authors":"Perpetua Uduba, Lissa Soares, Tesleem Babalola, Melissa Slotnick, Aaron Linder, Jaymie R Meliker","doi":"10.1097/HP.0000000000001880","DOIUrl":"10.1097/HP.0000000000001880","url":null,"abstract":"<p><strong>Abstract: </strong>Uranium is naturally occurring in groundwater used for drinking; however, health risks from naturally occurring concentrations are uncertain. Uranium can cause both radiological and chemical toxicity following ingestion. Bladder and kidneys receive a dose when uranium is excreted into the urine. Investigate the association between uranium in drinking water and bladder cancer risk in a case-control study. A population-based bladder cancer case-control study was conducted in 11 counties of southeastern Michigan. A total of 411 cases and 566 controls provided drinking water and toenail samples and answered questions about lifestyle and residential history. Uranium was measured in drinking water and toenails, and its association with bladder cancer was assessed via unconditional logistic regression models. Median uranium concentration in water was 0.12 μg L -1 , with a maximum of 4.99 μg L -1 , and median uranium concentration in toenails was 0.0031 μg g -1 . In adjusted regression models, there was a suggestion of a protective effect among those exposed to the upper quartile of uranium in drinking water (HR = 0.64, 95% CI: 0.43, 0.96) and toenails (HR 0.66; 95% CI 0.45, 0.96) compared to those in the lowest quartile. Our objective is to investigate additional adjustment of drinking water source at home residence at time of recruitment to address potential selection bias and confounding attenuated results toward the null for drinking water uranium (HR = 0.68, 95% CI: 0.44, 1.05) and toenail uranium (HR = 0.80, 95% CI: 0.53, 1.20). This case-control study showed no increased risk of bladder cancer associated with uranium found in drinking water or toenails.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"719-724"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-07-24DOI: 10.1097/HP.0000000000001872
Amber M Harshman, William L McCarter
Abstract: US Department of Energy national laboratories can play an integral role in not only the advancement of science but also in the treatment of various medical conditions through research and development activities conducted at radioisotope production facilities. A project has been underway at Oak Ridge National Laboratory since 2016 whose mission is to produce and supply the radioisotope 227 Ac, which is used in a radiopharmaceutical developed to treat certain types of prostate cancer and bone metastases. Production activities result in the environmental release of airborne radioactive emissions, which are governed by Clean Air Act regulations described in 40 CFR Part 61, Subpart H. Stack 3039, the source that emits radioactive effluents from 227 Ac production, is subject to additional requirements outlined in American National Standards Institute (ANSI) N13.1-1969 due to its grandfathered status. Radioactive emissions are limited to levels below those that would cause annual compliance dose standards for members of the public to be exceeded and stack 3039 to lose its grandfathered status. To allow for maximum production of 227 Ac without exceeding relevant dose limits, monthly tracking of project emissions and resulting CAP88-PC modeled effective doses to a maximally exposed individual have been implemented. Four years of tracking data were compiled and analyzed to identify additional methods that could be used to estimate project doses more frequently, potentially further optimizing 227 Ac production while maintaining compliance with applicable regulations.
{"title":"Methods to Track Effective Doses from Airborne Radioactive Emissions for Compliance with 40 CFR 61, SUBPART H.","authors":"Amber M Harshman, William L McCarter","doi":"10.1097/HP.0000000000001872","DOIUrl":"10.1097/HP.0000000000001872","url":null,"abstract":"<p><strong>Abstract: </strong>US Department of Energy national laboratories can play an integral role in not only the advancement of science but also in the treatment of various medical conditions through research and development activities conducted at radioisotope production facilities. A project has been underway at Oak Ridge National Laboratory since 2016 whose mission is to produce and supply the radioisotope 227 Ac, which is used in a radiopharmaceutical developed to treat certain types of prostate cancer and bone metastases. Production activities result in the environmental release of airborne radioactive emissions, which are governed by Clean Air Act regulations described in 40 CFR Part 61, Subpart H. Stack 3039, the source that emits radioactive effluents from 227 Ac production, is subject to additional requirements outlined in American National Standards Institute (ANSI) N13.1-1969 due to its grandfathered status. Radioactive emissions are limited to levels below those that would cause annual compliance dose standards for members of the public to be exceeded and stack 3039 to lose its grandfathered status. To allow for maximum production of 227 Ac without exceeding relevant dose limits, monthly tracking of project emissions and resulting CAP88-PC modeled effective doses to a maximally exposed individual have been implemented. Four years of tracking data were compiled and analyzed to identify additional methods that could be used to estimate project doses more frequently, potentially further optimizing 227 Ac production while maintaining compliance with applicable regulations.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"688-701"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01Epub Date: 2024-08-05DOI: 10.1097/HP.0000000000001875
Takahira Hitomi, Kudo Takashi, Ideguchi Reiko
Abstract: The ICRP 2011 Seoul Statement recommended a reduction in the dose limit for lens exposure to 100 mSv for 5 y and 50 mSv for 1 y. Based on this recommendation, the dose limit for lens exposure was lowered in Japan with the revision of the Ionization Regulations, which took effect in April 2021. In the present study, lens doses were measured during fluoroscopic procedures performed in four departments (Urology, Pediatrics, Gastroenterology, and Orthopedics). Lens doses were measured without protective eyewear for 6 mo (pre-intervention) and then with protective eyewear for the next 6 mo (post-intervention). Monthly doses were collected and lens doses before and after the use of protective eyewear were calculated as the lens dose per unit time. The use of protective eyewear reduced the lens dose per unit time by approximately two thirds. In all departments, the lens dose was slightly lower after than before the intervention. A significant difference was observed in lens doses between the pre- and post-intervention periods in the Urology department. The present results demonstrated the effectiveness of protective eyewear in daily practice. Therefore, the use of protective eyewear is recommended during fluoroscopic procedures.
{"title":"Effect of Protective Eyewear on Physicians' Lens Exposure during Fluoroscopy.","authors":"Takahira Hitomi, Kudo Takashi, Ideguchi Reiko","doi":"10.1097/HP.0000000000001875","DOIUrl":"10.1097/HP.0000000000001875","url":null,"abstract":"<p><strong>Abstract: </strong>The ICRP 2011 Seoul Statement recommended a reduction in the dose limit for lens exposure to 100 mSv for 5 y and 50 mSv for 1 y. Based on this recommendation, the dose limit for lens exposure was lowered in Japan with the revision of the Ionization Regulations, which took effect in April 2021. In the present study, lens doses were measured during fluoroscopic procedures performed in four departments (Urology, Pediatrics, Gastroenterology, and Orthopedics). Lens doses were measured without protective eyewear for 6 mo (pre-intervention) and then with protective eyewear for the next 6 mo (post-intervention). Monthly doses were collected and lens doses before and after the use of protective eyewear were calculated as the lens dose per unit time. The use of protective eyewear reduced the lens dose per unit time by approximately two thirds. In all departments, the lens dose was slightly lower after than before the intervention. A significant difference was observed in lens doses between the pre- and post-intervention periods in the Urology department. The present results demonstrated the effectiveness of protective eyewear in daily practice. Therefore, the use of protective eyewear is recommended during fluoroscopic procedures.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"712-718"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-27DOI: 10.1097/HP.0000000000001896
Mehdi Sohrabi, Sahel Rabiee
Abstract: An electret detector is a piece of dielectric material film charged or polarized by a specific charging method to induce a quasi-permanent electric field. Electret films perform unique characteristics for production and applications in many areas of science and technology, especially in health physics dosimetry. A charged electret detector, when placed in an ionized environment, collects negative or positive ions depending on its original charging state, which reduces its original charge. The number of charges reduced in the ionized field is usually proportional to the absorbed radiation dose. In this paper, the state-of-the-art information on the type of electrets, production methods, some applications in particular in health physics dosimetry, and relevant concepts are reviewed.
{"title":"Electret Production and Applications with Special Regard to Health Physics Dosimetry: A Review.","authors":"Mehdi Sohrabi, Sahel Rabiee","doi":"10.1097/HP.0000000000001896","DOIUrl":"https://doi.org/10.1097/HP.0000000000001896","url":null,"abstract":"<p><strong>Abstract: </strong>An electret detector is a piece of dielectric material film charged or polarized by a specific charging method to induce a quasi-permanent electric field. Electret films perform unique characteristics for production and applications in many areas of science and technology, especially in health physics dosimetry. A charged electret detector, when placed in an ionized environment, collects negative or positive ions depending on its original charging state, which reduces its original charge. The number of charges reduced in the ionized field is usually proportional to the absorbed radiation dose. In this paper, the state-of-the-art information on the type of electrets, production methods, some applications in particular in health physics dosimetry, and relevant concepts are reviewed.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142727888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-20DOI: 10.1097/HP.0000000000001914
James Kyle Underwood, Glenn M Sturchio
Abstract: Many medical facilities across the United States use ionizing-radiation-producing machines and radioactive materials for diagnostic and therapeutic purposes on a regular basis. While institutions are required to ensure full-term fetal doses are below the regulatory limit, clear guidance on how pre-declaration fetal doses should be estimated is not available. This paper provides a process that can be used to estimate the pre-declaration fetal dose and provides a predictive screening tool for licensees to use to recommend workload adjustments prior to actual fetal dosimetry results that could exceed the institutions derived investigation levels. The evaluation process presented herein serves as a guide for medical licensees when performing fetal dose evaluations for declared pregnant workers.
{"title":"Pre-declaration Fetal Dose Assignment and Predictive Full term Fetal Dose at Medical Facilities.","authors":"James Kyle Underwood, Glenn M Sturchio","doi":"10.1097/HP.0000000000001914","DOIUrl":"https://doi.org/10.1097/HP.0000000000001914","url":null,"abstract":"<p><strong>Abstract: </strong>Many medical facilities across the United States use ionizing-radiation-producing machines and radioactive materials for diagnostic and therapeutic purposes on a regular basis. While institutions are required to ensure full-term fetal doses are below the regulatory limit, clear guidance on how pre-declaration fetal doses should be estimated is not available. This paper provides a process that can be used to estimate the pre-declaration fetal dose and provides a predictive screening tool for licensees to use to recommend workload adjustments prior to actual fetal dosimetry results that could exceed the institutions derived investigation levels. The evaluation process presented herein serves as a guide for medical licensees when performing fetal dose evaluations for declared pregnant workers.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-20DOI: 10.1097/HP.0000000000001928
Yadin Cohen, Jon Feldman, Vibha Chaswal, Sarah Heard, Evelyn Shin, Giacomo Feliciani, Jean-Yves Giraud, Eleonora Kuptzov
Abstract: Alpha DaRT is a new alpha radiation treatment for treating solid tumors and is currently being evaluated through clinical trials worldwide. Being a novel radiation treatment, it is important to discuss the safety considerations and procedures that are needed to ensure safe use of this unique approach. The objective of this article is to provide a set of recommendations-radiation safety best practices that were developed based on operational and clinical experience.
{"title":"Clinical Best Practices for Radiation Safety During an Alpha DaRT Treatment.","authors":"Yadin Cohen, Jon Feldman, Vibha Chaswal, Sarah Heard, Evelyn Shin, Giacomo Feliciani, Jean-Yves Giraud, Eleonora Kuptzov","doi":"10.1097/HP.0000000000001928","DOIUrl":"https://doi.org/10.1097/HP.0000000000001928","url":null,"abstract":"<p><strong>Abstract: </strong>Alpha DaRT is a new alpha radiation treatment for treating solid tumors and is currently being evaluated through clinical trials worldwide. Being a novel radiation treatment, it is important to discuss the safety considerations and procedures that are needed to ensure safe use of this unique approach. The objective of this article is to provide a set of recommendations-radiation safety best practices that were developed based on operational and clinical experience.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-20DOI: 10.1097/HP.0000000000001903
Nicky Nivi, Helen Moise, Ana Pejović-Milić
Abstract: This work investigates the low photon radiation dose (≤50 mSv) response of commercially available radiochromic films as a potential field dosimeter that could be used by the Canadian Armed Forces to complement their existing personal radiation dosimeters. The films were exposed to various photon energies from x-ray devices and radioisotopes (cesium-137, cobalt-60, and americium-241), and their radiation signal was read using three methods: net optical density, UV/visible spectroscopy, and Fourier transform infrared spectroscopy. A complimentary film dosimeter for field usage should, for military use, display a visual color change and detect doses ≤50 mSv. Given the film's radiochromic properties, it was determined that the net optical density method was the most optimal read-out method, which ascertained a minimum detection dose limit of 4.5 mSv under exposure to a clinical orthovoltage operated at 100 kVp. The film presented an overall linear relationship between net optical density and radiation dose; however, they also portrayed a photon energy-dependent response between 0-100 mSv. Overall, the radiochromic films presented a real-time visual dose signal that could be interpreted rapidly in a mobile laboratory and possessed the ability to detect photon doses ≤50 mSv below the vendor's recommended limits, making it a suitable option as a complementary, disposable, military dosimetric tool. Future work includes the investigation of the film's response under multi- and unknown source environments and environmental-dependent factors such as UV/sunlight exposure and extreme temperatures.
{"title":"Evaluation of a Commercially Available Radiochromic Film for Use as a Complementary Dosimeter for Rapid In-field Low Photon Equivalent Radiation Dose (≤50 mSv) Monitoring.","authors":"Nicky Nivi, Helen Moise, Ana Pejović-Milić","doi":"10.1097/HP.0000000000001903","DOIUrl":"https://doi.org/10.1097/HP.0000000000001903","url":null,"abstract":"<p><strong>Abstract: </strong>This work investigates the low photon radiation dose (≤50 mSv) response of commercially available radiochromic films as a potential field dosimeter that could be used by the Canadian Armed Forces to complement their existing personal radiation dosimeters. The films were exposed to various photon energies from x-ray devices and radioisotopes (cesium-137, cobalt-60, and americium-241), and their radiation signal was read using three methods: net optical density, UV/visible spectroscopy, and Fourier transform infrared spectroscopy. A complimentary film dosimeter for field usage should, for military use, display a visual color change and detect doses ≤50 mSv. Given the film's radiochromic properties, it was determined that the net optical density method was the most optimal read-out method, which ascertained a minimum detection dose limit of 4.5 mSv under exposure to a clinical orthovoltage operated at 100 kVp. The film presented an overall linear relationship between net optical density and radiation dose; however, they also portrayed a photon energy-dependent response between 0-100 mSv. Overall, the radiochromic films presented a real-time visual dose signal that could be interpreted rapidly in a mobile laboratory and possessed the ability to detect photon doses ≤50 mSv below the vendor's recommended limits, making it a suitable option as a complementary, disposable, military dosimetric tool. Future work includes the investigation of the film's response under multi- and unknown source environments and environmental-dependent factors such as UV/sunlight exposure and extreme temperatures.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-08DOI: 10.1097/HP.0000000000001891
Christine Karbiwnyk, Philip Stafford, Elon Malkin, Kelly Garnick, Thomas A Scott, Cong Wei
Abstract: After some consumer products indicated elevated levels of 232Th progeny by gamma-ray spectrometry, a microwave digestion and inductively coupled plasma-mass spectrometry (ICP-MS) procedure was implemented for the direct assay of 232Th content to ensure compliance with Federal regulations and guidelines. Levels of 232Th were determined by ICP-MS based on standard calibration using a 205Tl internal standard. The method had a method detection limit (MDL) of 0.15 Bq g-1 and a lower limit of quantification (LLOQ) of 0.65 Bq g-1 for 232Th, making it a suitable confirmatory method following gamma-ray spectrometry. The 232Th activity concentration calculated from the ICP-MS results ranged from 2.0-3.4 Bq g-1 for the kinesiology tape samples and 20 Bq g-1 for the silicone ion bracelet. The VARSKIN+1.0 software program was used to calculate the shallow dose equivalent of ionizing radiation from 232Th and its progeny from the ICP-MS results. The skin dose to the consumer wearing the kinesiology tape ranged from 0.48-1.6 mSv y-1. The skin dose to the consumer with constant wear of the silicone ion bracelet was estimated to be 17 mSv y-1. Although 232Th may be determined indirectly by assay of high abundance gamma rays produced by its progeny, the US Code of Federal Regulations (CFR) requires the direct assay of 232Th for confirmatory analysis. We found this ICP-MS method to be a rapid 232Th confirmatory technique compared to a chemical separation followed by alpha spectrometry procedure.
{"title":"Ionizing Radiation Dose to the Skin Assessed after Rapid Detection of 232Th in Consumer Products.","authors":"Christine Karbiwnyk, Philip Stafford, Elon Malkin, Kelly Garnick, Thomas A Scott, Cong Wei","doi":"10.1097/HP.0000000000001891","DOIUrl":"https://doi.org/10.1097/HP.0000000000001891","url":null,"abstract":"<p><strong>Abstract: </strong>After some consumer products indicated elevated levels of 232Th progeny by gamma-ray spectrometry, a microwave digestion and inductively coupled plasma-mass spectrometry (ICP-MS) procedure was implemented for the direct assay of 232Th content to ensure compliance with Federal regulations and guidelines. Levels of 232Th were determined by ICP-MS based on standard calibration using a 205Tl internal standard. The method had a method detection limit (MDL) of 0.15 Bq g-1 and a lower limit of quantification (LLOQ) of 0.65 Bq g-1 for 232Th, making it a suitable confirmatory method following gamma-ray spectrometry. The 232Th activity concentration calculated from the ICP-MS results ranged from 2.0-3.4 Bq g-1 for the kinesiology tape samples and 20 Bq g-1 for the silicone ion bracelet. The VARSKIN+1.0 software program was used to calculate the shallow dose equivalent of ionizing radiation from 232Th and its progeny from the ICP-MS results. The skin dose to the consumer wearing the kinesiology tape ranged from 0.48-1.6 mSv y-1. The skin dose to the consumer with constant wear of the silicone ion bracelet was estimated to be 17 mSv y-1. Although 232Th may be determined indirectly by assay of high abundance gamma rays produced by its progeny, the US Code of Federal Regulations (CFR) requires the direct assay of 232Th for confirmatory analysis. We found this ICP-MS method to be a rapid 232Th confirmatory technique compared to a chemical separation followed by alpha spectrometry procedure.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}